Discovery and pharmacology of varenicline: An a4b2 nAChR partial agonist for smoking cessation

被引：0
|
作者：
Rollema, H. [1 ]
Coe, J. W. [1 ]
机构：
[1] Pfizer Inc, Global Res & Dev, Groton Labs, Groton, CT 06340 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
    Coe, JW
    Brooks, PR
    Vetelino, MG
    Wirtz, MC
    Arnold, EP
    Huang, JH
    Sands, SB
    Davis, TI
    Lebel, LA
    Fox, CB
    Shrikhande, A
    Heym, JH
    Schaeffer, E
    Rollema, H
    Lu, Y
    Mansbach, RS
    Chambers, LK
    Rovetti, CC
    Schulz, DW
    Tingley, FD
    O'Neill, BT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (10) : 3474 - 3477
  • [2] Varenicline tartrate -: Aid to smoking cessation -: Nicotinic α4β2 partial agonist
    Sorbera, LA
    Castañer, J
    [J]. DRUGS OF THE FUTURE, 2006, 31 (02) : 117 - 122
  • [3] Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition
    Rollema, Hans
    Hajos, Mihaly
    Seymour, Patricia A.
    Kozak, Rouba
    Majchrzak, Mark J.
    Guanowsky, Victor
    Horner, Weldon E.
    Chapin, Doug S.
    Hoffmann, William E.
    Johnson, David E.
    Mclean, Stafford
    Freeman, Jody
    Williams, Kathryn E.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2009, 78 (07) : 813 - 824
  • [4] Smoking cessation efficacy and safety of varenicline, an α4β2 nicotinic receptor partial agonist
    Tonstad, Serena
    [J]. JOURNAL OF CARDIOVASCULAR NURSING, 2006, 21 (06) : 433 - 436
  • [5] Varenicline - An oral partial nicotine agonist for smoking cessation
    Feret, Brett
    Orr, Kelly
    [J]. FORMULARY, 2006, 41 (06) : 265 - +
  • [6] Pharmacology of varenicline, a clinically effective alpha4beta2 nicotinic acetylcholine receptor partial agonist for smoking cessation
    Rollema, Hans
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S19 - S19
  • [7] Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
    Rollema, H.
    Chambers, L. K.
    Coe, J. W.
    Glowa, J.
    Hurst, R. S.
    Lebel, L. A.
    Lu, Y.
    Mansbach, R. S.
    Mather, R. J.
    Rovetti, C. C.
    Sands, S. B.
    Schaeffer, E.
    Schulz, D. W.
    Tingley, F. D., III
    Williams, K. E.
    [J]. NEUROPHARMACOLOGY, 2007, 52 (03) : 985 - 994
  • [8] Efficacy and safety of varenicline, an α4β2 acetylcholine nicotinic receptor partial agonist, for smoking cessation in Japanese smokers
    Nakamura, Masakazu
    Fujimoto, Yoko
    Maruyama, Nami
    Ishibashi, Taro
    Reeves, Karen
    [J]. CIRCULATION, 2006, 114 (18) : 856 - 856
  • [9] Discovery and development of varenicline for smoking cessation
    Jordan, Chloe J.
    Xi, Zheng-Xiong
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (07) : 671 - 683
  • [10] The efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation in Taiwanese and Korean smokers
    Kim, Dac-Hyun
    Tsai, Shih-Tzu
    Cho, Hong-Jun
    Chang, Wen-Dau
    Kim, Cheol-Hwan
    Cheng, Huey-Shinn
    Cho, BeLong
    Guo, Fei-Rarl
    Paek, Yu-Jin
    Hsueh, Kuang-Chieh
    Billing, Clare B., Jr.
    Williams, Kathryn E.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 82 - 82
12345